BeOne Medicines (ONC) Change in Taxes (2016 - 2021)
BeOne Medicines (ONC) posted quarterly Change in Taxes of $7.1 million for Q1 2021, up 17.58% year-over-year from $6.1 million in Q1 2020, and down 51.0% quarter-over-quarter from $14.6 million in Q4 2020.
BeOne Medicines (ONC) Change in Taxes (2016 - 2021) Analysis & Trends
BeOne Medicines (ONC) has reported Change in Taxes for 6 consecutive years, with $7.1 million the latest figure, recorded in Q1 2021.
- In Q1 2021, Change in Taxes rose 17.58% year-over-year to $7.1 million; the TTM figure through Mar 2021 stood at $3.4 million (down 73.27% YoY), while the FY2020 annual figure was $2.3 million, down 69.35% from the prior year.
- Change in Taxes fell to $7.1 million in Q1 2021 per ONC's latest filing, from $14.6 million in the prior quarter.
- Across five years, Change in Taxes topped out at $14.6 million in Q4 2020 and bottomed at -$9.3 million in Q3 2020.
- Historically, Change in Taxes has averaged $1.2 million across 5 years, with a median of $969000.0 in 2019.
- Annual changes were most pronounced in 2017 — Change in Taxes soared 5251.52% — and 2018, when it sank 1730.22%.
- BeOne Medicines' Change in Taxes stood at $6.3 million in 2017, then tumbled by 32.55% to $4.3 million in 2018, then gained by 3.32% to $4.4 million in 2019, then surged by 232.14% to $14.6 million in 2020, then plunged by 51.0% to $7.1 million in 2021.
- Business Quant data shows ONC's Change in Taxes at $7.1 million in Q1 2021, $14.6 million in Q4 2020, and -$9.3 million in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -10.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 7.15 Mn |
| Mar 31, 2021 | 7.15 Mn |
| Dec 31, 2020 | 14.59 Mn |
| Dec 31, 2020 | 14.59 Mn |
| Sep 30, 2020 | -9.27 Mn |
| Sep 30, 2020 | -9.27 Mn |
| Jun 30, 2020 | -9.09 Mn |
| Jun 30, 2020 | -9.09 Mn |
| Mar 31, 2020 | 6.08 Mn |
| Mar 31, 2020 | 6.08 Mn |
| Dec 31, 2019 | 4.39 Mn |
| Dec 31, 2019 | 4.39 Mn |
| Sep 30, 2019 | 6.89 Mn |
| Sep 30, 2019 | 6.89 Mn |
| Jun 30, 2019 | -4.68 Mn |
| Jun 30, 2019 | -4.68 Mn |
| Mar 31, 2019 | 969,000.00 |
| Mar 31, 2019 | 969,000.00 |
| Dec 31, 2018 | 4.25 Mn |
| Dec 31, 2018 | 4.25 Mn |